Steven A Kaplan Selected Research

Overactive Urinary Bladder (Overactive Bladder)

12/2021	Outcomes of combination therapy with daily tadalafil 5 mg plus tamsulosin 0.4 mg to treat lower urinary tract symptoms and erectile dysfunction in men with or without metabolic syndrome.
1/2021	Efficacy and Safety of Mirabegron in Men with Overactive Bladder Symptoms and Benign Prostatic Hyperplasia.
1/2021	Mirabegron Vs Placebo Add-on Therapy in Men With Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis From the Randomized, Phase 4 PLUS Study.
1/2020	Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS).
2/2019	Do patient characteristics predict which patients with overactive bladder benefit from a higher fesoterodine dose?
1/2019	Re: Safety and Effectiveness of Mirabegron in Patients with Overactive Bladder in a Real-World Clinical Setting: A Japanese Post-Marketing Study.
1/2018	Systematic review and meta-analysis on the efficacy and tolerability of mirabegron for the treatment of storage lower urinary tract symptoms/overactive bladder: Comparison with placebo and tolterodine.
10/2017	Characteristics of antimuscarinic responders versus suboptimal responders in a randomized clinical trial of patients with overactive bladder symptoms.
1/2017	Re: Effectiveness of Solifenacin and Trospium for Managing of Severe Symptoms of Overactive Bladder in Patients with Benign Prostatic Hyperplasia.
3/2016	The concomitant use of fesoterodine and topical vaginal estrogen in the management of overactive bladder and sexual dysfunction in postmenopausal women.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven A Kaplan Research Topics

Disease

171	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 02/2022 - 10/2002
94	Lower Urinary Tract Symptoms 02/2022 - 04/2004
35	Overactive Urinary Bladder (Overactive Bladder) 12/2021 - 05/2006
18	Urinary Retention 01/2020 - 04/2003
17	Erectile Dysfunction 12/2021 - 06/2006
16	Prostatic Neoplasms (Prostate Cancer) 12/2020 - 04/2003
12	Urinary Incontinence 02/2019 - 12/2003
10	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 10/2021 - 07/2003
9	Nocturia 01/2020 - 08/2006
8	Hyperplasia 11/2020 - 10/2004
6	Inflammation (Inflammations) 03/2016 - 04/2005
6	Disease Progression 02/2014 - 12/2003
5	Constipation 02/2019 - 05/2006
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021 - 10/2006
4	Neoplasms (Cancer) 06/2021 - 05/2009
4	Hemorrhage 01/2021 - 12/2005
4	Dizziness (Lightheadedness) 01/2016 - 05/2006
4	Urge Urinary Incontinence (Urge Incontinence) 06/2015 - 11/2008
4	Prostatitis 09/2011 - 01/2004
3	Hypertension (High Blood Pressure) 01/2018 - 03/2006
2	Pain (Aches) 06/2021 - 01/2004
2	Myocardial Infarction 01/2021 - 11/2016
2	Neoplasm Metastasis (Metastasis) 08/2020 - 01/2018
2	Dementia (Dementias) 01/2020 - 01/2019
2	Urethral Stricture 10/2017 - 01/2006
2	Orthostatic Hypotension (Postural Hypotension) 01/2016 - 06/2006
2	Hypogonadism (Hypergonadotropic Hypogonadism) 03/2015 - 06/2010
2	Stress Urinary Incontinence 11/2014 - 07/2013
2	Ejaculatory Dysfunction 08/2012 - 10/2011
2	Renal Insufficiency (Renal Failure) 01/2006 - 12/2003
2	Urinary Tract Infections (Urinary Tract Infection) 01/2006 - 12/2003
2	Pelvic Pain 12/2005 - 01/2004
1	Epilepsy (Aura) 06/2021
1	Mood Disorders (Mood Disorder) 06/2021
1	Nervous System Diseases (Neurological Disorders) 06/2021
1	Gynecomastia 04/2021
1	Lacunar Stroke 01/2021
1	Angina Pectoris 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Cerebral Infarction 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2020
1	Urologic Neoplasms (Urological Cancer) 08/2020
1	Kidney Neoplasms (Kidney Cancer) 08/2020

Drug/Important Bio-Agent (IBA)

35	Tamsulosin (Flomax)FDA LinkGeneric 12/2021 - 11/2006
22	Finasteride (Propecia)FDA LinkGeneric 04/2021 - 10/2002
18	Tolterodine Tartrate (Detrol)FDA Link 01/2018 - 12/2005
17	Dutasteride (Avodart)FDA Link 01/2020 - 11/2005
16	Tadalafil (Cialis)FDA Link 12/2021 - 06/2006
14	Muscarinic AntagonistsIBA 01/2020 - 11/2006
12	Testosterone (Sustanon)FDA Link 01/2017 - 03/2006
11	Prostate-Specific Antigen (Semenogelase)IBA 07/2014 - 04/2005
10	Phosphodiesterase 5 InhibitorsIBA 01/2020 - 06/2006
8	mirabegronIBA 01/2021 - 02/2013
8	Solifenacin Succinate FDA Link 01/2020 - 12/2009
8	Doxazosin (Cardura)FDA LinkGeneric 01/2016 - 12/2003
7	Pharmaceutical PreparationsIBA 02/2022 - 12/2003
7	fesoterodine FDA Link 02/2019 - 05/2011
5	Cholinergic Antagonists (Anticholinergics)IBA 01/2020 - 01/2013
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 07/2002
4	SteamIBA 01/2020 - 01/2019
4	Gonadal Steroid Hormones (Sex Hormones)IBA 10/2017 - 11/2011
3	saw palmetto extractIBA 01/2020 - 01/2004
3	LipidsIBA 01/2019 - 10/2006
3	Estrogens (Estrogen)FDA Link 01/2017 - 11/2011
3	Sildenafil Citrate (Viagra)FDA Link 09/2013 - 01/2007
3	alfuzosin (UroXatral)FDA Link 09/2013 - 06/2006
2	Metformin (Glucophage)FDA LinkGeneric 12/2020 - 01/2019
2	salicylhydroxamic acid (SHAM)IBA 01/2020 - 12/2016
2	CholesterolIBA 10/2019 - 10/2006
2	nitinolIBA 01/2019 - 01/2016
2	Androgen Receptors (Androgen Receptor)IBA 01/2018 - 03/2013
2	Cholinergic Agents (Cholinergics)IBA 03/2016 - 01/2012
2	silodosin FDA Link 03/2015 - 01/2011
2	Dihydrotestosterone (Androstanolone)IBA 01/2013 - 07/2007
2	Botulinum Toxins (Botulinum Toxin)IBA 09/2012 - 01/2005
2	Adrenergic Agents (Adrenergic Drugs)IBA 10/2011 - 03/2004
2	naftopidilIBA 01/2011 - 09/2005
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 02/2007 - 01/2006
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 08/2006 - 06/2006
2	Adrenergic Receptors (Adrenergic Receptor)IBA 03/2006 - 04/2003
2	potassium titanylphosphateIBA 01/2006 - 12/2004
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2021
1	EndocannabinoidsIBA 06/2021
1	fexapotide triflutateIBA 12/2020
1	QuinazolinesIBA 08/2020
1	IntegrinsIBA 08/2020
1	Trace Elements (Biometals)IBA 11/2019
1	SteroidsIBA 10/2019

Therapy/Procedure

64	Therapeutics 12/2021 - 10/2002
16	Transurethral Resection of Prostate (TURP) 07/2021 - 07/2003
12	Prostatectomy (Retropubic Prostatectomy) 01/2019 - 01/2003
9	Laser Therapy (Surgery, Laser) 01/2019 - 12/2004
9	Lasers (Laser) 01/2019 - 01/2003
7	Catheters 02/2022 - 07/2003
6	Aftercare (After-Treatment) 02/2022 - 09/2012
6	Solid-State Lasers 11/2020 - 12/2005
2	Drug Therapy (Chemotherapy) 01/2016 - 12/2013
2	Suburethral Slings (Tension-Free Vaginal Tape) 11/2014 - 07/2013
1	Minimally Invasive Surgical Procedures 08/2021
1	Cautery 01/2021